“Synterex values the meaningful relationships we have forged with our clients in the EU, and we are looking forward to our EU expansion as a way to better serve their needs."
DEDHAM, Mass. (PRWEB) January 06, 2023
Clinical and regulatory consulting firm Synterex, Inc. has announced the opening of a new European Union (EU) office in Amsterdam, Netherlands, with additional global expansion planned in 2023.
Since the company’s inception, Synterex staff has applied their years of experience in clinical writing and development to help clients successfully deliver important new therapies to patients. Synterex has produced high-quality regulatory documents for clients across the globe and employed disruptive and novel submission strategies to achieve impactful approvals in record time. Much of this work has included the development of regulatory documents for the European Medicines Agency such as marketing applications and EU orphan drug applications. Opening a new EU office will allow Synterex to continue delivering best-in-class regulatory services to clients and to provide a broader base of service to existing global customers.
“Synterex values the meaningful relationships we have forged with our clients in the EU, and we are looking forward to our EU expansion as a way to better serve their needs,” said Synterex President Jeanette Towles. “Having a base of service in Europe will help us strengthen our service capabilities outside of the United States. It is the logical next step in meeting our company’s goal of getting new medicines to as many patients as possible.”
For more information on Synterex and its leadership, visit: http://www.synterex.com.
About Synterex, Inc.:
Synterex is a WBENC-Certified Women's Business Enterprise and disability-owned global clinical and regulatory consulting firm that provides clinical development solutions.
Delivering quality regulatory documentation requires navigating an evolving landscape influenced by regulators, research committees, healthcare professionals, and—most importantly—the scientific method itself.
At Synterex, we forge lasting and meaningful relationships that flex with the dynamic nature of science and technology.
Our staffers are seasoned and dedicated, with extensive experience doing the work hands-on as well as building and leading teams. We are committed to applying our years of experience and current subject matter and technical knowledge to help clients deliver important new therapies to patients in an expedient manner.